Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06314971 · ClinicalTrials.gov registry record

Predicting Local and Distant Recurrence in T1 Colorectal Cancer

A clinical trial of Colorectal Cancer and Colorectal Neoplasms, sponsored by City of Hope Medical Center.

Completed
Registry status
138
Enrollment target
3
Study locations

NCT06314971 is a study of Colorectal Cancer and Colorectal Neoplasms that has completed, run by City of Hope Medical Center. The registered enrollment target is 138 participants, below the 1,511-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (91% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06314971, a study of Colorectal Cancer and Colorectal Neoplasms, has completed, sponsored by City of Hope Medical Center.

COMPLETED
Registry status
138 participants
Enrollment target
3
Study locations

Study Summary

Tumor recurrence significantly affects survival rates following the local resection of submucosal colorectal cancers (T1 CRC). Despite this, there are currently no reliable biomarkers established to predict recurrence in T1 CRC. This study seeks to improve the prediction of recurrence-free survival in individuals who have survived T1 CRC.

Conditions Studied

Colorectal Cancer Colorectal Neoplasms Colorectal Adenocarcinoma Colorectal Cancer Stage I Colorectal Cancer Recurrent Colorectal Neoplasms Malignant

Interventions

  • OTHER Tw1CE

Study Locations (3)

Other

  • Tokushima University - Tokushima
  • Barcelona University - Barcelona

California

  • City of Hope Medical Center - Duarte

Trial Details

FieldValue
Enrollment Target 138 participants
Start Date 2023-03-15
Est. Completion 2025-06-30

Sponsor

City of Hope Medical Center

582 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06314971

The ClinicalTrials.gov registry entry for NCT06314971 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,511-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (91% lower). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Tw1CE is the first listed.

NCT06314971 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Other, California.

Frequently Asked Questions

What is clinical trial NCT06314971 about?

NCT06314971 is a clinical study titled "Predicting Local and Distant Recurrence in T1 Colorectal Cancer". Tumor recurrence significantly affects survival rates following the local resection of submucosal colorectal cancers (T1 CRC). Despite this, there are currently no reliable biomarkers established to predict recurrence in T1 CRC. This study seeks to improve the prediction of recurrence-free survival...

What is the current status of trial NCT06314971?

This trial is currently completed. The enrollment target is 138 participants. The study started on 2023-03-15. Estimated completion is 2025-06-30.

What conditions does trial NCT06314971 study?

This clinical trial studies the following conditions: Colorectal Cancer, Colorectal Neoplasms, Colorectal Adenocarcinoma, Colorectal Cancer Stage I, Colorectal Cancer Recurrent.

What interventions are being tested in trial NCT06314971?

The interventions under investigation include: Tw1CE (OTHER).

Who is sponsoring clinical trial NCT06314971?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06314971 being conducted?

This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Colorectal Cancer

All registered trials for this condition

Colorectal Neoplasms

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.